<?xml version="1.0" encoding="UTF-8"?>
<p>The 
 <italic>ex vivo</italic> clinical study performed by Minich 
 <italic>et al</italic>. on pain relief used a combination similar to ‘Meta050’, but is here presented as NG440. The goal was to examine the clinical safety and efficacy of NG440. The report suggested that NG440 is safe for human consumption and that animal toxicity revealed no adverse effects, at daily dosages ≤250 mg/kg. According to these results, NG440 may serve as an alternative where specific COX-2 inhibitors have been traditionally used [
 <xref rid="B111" ref-type="bibr">111</xref>].
</p>
